Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"neutralizing response"”.

  1. CARATTERIZZAZIONE VIROLOGICA E DETERMINAZIONE DELLA RISPOSTA NEUTRALIZZANTE IN PAZIENTI PEDIATRICI CON INFEZIONE DA HIV-1.

    … pairs as well as to characterize the neutralizing response in seropositive children with different disease progression. We have investigated in detail the phenotype of the clonal viral population and in specific the capacity to infect in vitro target cells expressing CCR5/CXCR4 …

    milano Repository record for CARATTERIZZAZIONE VIROLOGICA E DETERMINAZIONE DELLA RISPOSTA NEUTRALIZZANTE IN PAZIENTI PEDIATRICI CON INFEZIONE DA HIV-1. (opens in a new tab) Restricted access

  2. Intranasal immunization with immunogenic epitopes of pasteurella hemolytica and cholera toxin subunit B

    … producing a monoclonal antibody capable of neutralizing the leukotoxin was cloned. Studies with this monoclonal antibody indicated that it recognized an epitope in the carboxyl one-third of the toxin. This epitope was,located by fragmentation of the carboxyl domain. These fragments were used …

    ut-knoxville Repository record for Intranasal immunization with immunogenic epitopes of pasteurella hemolytica and cholera toxin subunit B (opens in a new tab)

  3. Effect of prior flavivirus immunity on the adaptive response to the yellow fever 17D vaccine

    … immunity, potentially influencing immune responses. Here, I investigated the impact of pre-existing flavivirus immunity induced by the tick-borne encephalitis virus vaccine (TBEV) on the response to YF17D vaccination in 250 individuals up to 28 days post-vaccination (pv). Previous TBEV …

    lmu-germany Repository record for Effect of prior flavivirus immunity on the adaptive response to the yellow fever 17D vaccine (opens in a new tab)

  4. Development of HPV Next-Generation Virus-Like Particle Vaccines That Are Cross-Protective

    … Both techniques result in high-titer antibody responses against the target epitope. Indeed, vaccines of VLPs are already available, including the two vaccines targeting Human Papillomavirus (HPV). These vaccines are very effective at preventing infection by the HPV types included in their …

    unm Repository record for Development of HPV Next-Generation Virus-Like Particle Vaccines That Are Cross-Protective (opens in a new tab)

  5. Development of Virus-like particles (VLPs) Based Vaccines Against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Porcine Epidemic Diarrhea Virus (PEDV)

    … GP3-4 was able to stimulate a significant viral neutralizing response in mouse sera against two PRRSV strains, one being heterologous, demonstrating its potential of cross-protection against PRRSV. The second animal study took an optimized VLP vaccine candidate against PEDV from previous …

    vt Repository record for Development of Virus-like particles (VLPs) Based Vaccines Against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Porcine Epidemic Diarrhea Virus (PEDV) (opens in a new tab)

  6. West Nile virus vaccination protects against Usutu virus disease in mice

    … (E) protein on the outside of the virion. Neutralizing antibodies against both WNV and USUV have been found in birds and humans across Europe. In vitro cross-neutralization of WNV and USUV has been modeled experimentally and been observed in clinical settings. The neutralizing antibody …

    vt Repository record for West Nile virus vaccination protects against Usutu virus disease in mice (opens in a new tab)

  7. EVOLUZIONE DEL TROPISMO DI HIV-1 IN RELAZIONE ALLE MODIFICAZIONI DI LINFOCITI CD4 E VIREMIA E AL TRATTAMENTO: STUDIO PROSPETTIVO DI COORTE IN PAZIENTI CON INFEZIONE ACUTA/RECENTE E PAZIENTI AIDS PRESENTERS

    … before the immune system is able to prepare a neutralizing response to contain the infection. AIDS represents a decrease in immune competence after a stage of clinical latency. The sequence analyses from amplification of the V3 region of gp120 within the env gene and the correlation with the …

    milano Repository record for EVOLUZIONE DEL TROPISMO DI HIV-1 IN RELAZIONE ALLE MODIFICAZIONI DI LINFOCITI CD4 E VIREMIA E AL TRATTAMENTO: STUDIO PROSPETTIVO DI COORTE IN PAZIENTI CON INFEZIONE ACUTA/RECENTE E PAZIENTI AIDS PRESENTERS (opens in a new tab)

  8. Anticorpos anti-flaviviridae nas síndromes de Guillain-Barré e congênita associada à infecção pelo vírus Zika

    … of serological diagnosis efficacy and antibody response profile are two great issues in ZIKV infection. Serological diagnosis is mainly performed by detection of antiNS1 antibodies, but there is evidence about cross-reactivity with antibodies against other flaviviruses, which impairs the ZIKV …

    brazil-ufrn Repository record for Anticorpos anti-flaviviridae nas síndromes de Guillain-Barré e congênita associada à infecção pelo vírus Zika (opens in a new tab)

  9. Understanding SARS-CoV-2 antigenic evolution using complete genotype-to-phenotype maps of the effects of mutations on antibody binding

    … have emerged. The RBD is also a major target of neutralizing antibodies that can block the virus' ability to enter cells. We extended the deep mutational scanning system to comprehensively measure the effects of mutations to the RBD on antibody binding. We found that the resulting antibody-escape …

    washington Repository record for Understanding SARS-CoV-2 antigenic evolution using complete genotype-to-phenotype maps of the effects of mutations on antibody binding (opens in a new tab)

  10. BIOMEDICAL, IMMUNOLOGICALS AND EPIDEMIOLOGICAL STUDIES ON LEISHMANIA

    … as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of LeCoVax-2, a candidate vaccine against COVID-1G. [pubblicato in: Pharmacological Research] Questo studio esplora il potenziale dei cloni ricombinanti di L. tarentolae come veicolo per la …

    milano Repository record for BIOMEDICAL, IMMUNOLOGICALS AND EPIDEMIOLOGICAL STUDIES ON LEISHMANIA (opens in a new tab)

  11. The Ontogeny of Mucosal and Systemic Antibody Responses to HIV-1 Infection

    … of virus-infected cells. The initial antibody response to HIV-1 infection is targeted to non-neutralizing epitopes on HIV-1 Env gp41, and when a neutralizing response does develop months after transmission, it is specific for the autologous founder virus and the virus escapes rapidly. After …

    duke Repository record for The Ontogeny of Mucosal and Systemic Antibody Responses to HIV-1 Infection (opens in a new tab)